Sequent Scientific’s wholly owned subsidiary, Alivira Animal Health (Alivira) has acquired 60% stake in Provet Veterinary Products AS, Turkey (Provet). The company earlier on September 10, 2014 had entered into an agreement to acquire 60% stake in Provet.
Provet is amongst top 5 in veterinary medicine providers in Turkey. With a ready portfolio of over 100 formulations, largely in the difficult space of injectibles and a newly established state-of-the-art facility which would soon be offered for EU GMP approval, Provet will accelerate Alivira’s foray in the global veterinary market.
Sequent Scientific is an integrated pharmaceutical company with a global footprint headquartered in Bangalore, India which has presence in different pharmaceutical verticals including APIs, Animal Health, Analytical Services, CRAMS and specialty chemicals. Sequent is the world's largest producer of Anthelmintics and by far the strongest player in the Veterinary API business.
